Dual REmission in Moderate-to-SEvere asthMa and Nasal Polyps
NCT07574294
·
clinicaltrials.gov ↗
COMPLETED
Status
205
Enrollment
OTHER
Sponsor class
Conditions
Asthma
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Interventions
OTHER:
Not applicable- observational study
DRUG:
Dupilumab
Sponsor
Azienda Ulss 2 Marca Trevigiana